Signal from the log
1nhaler
2,2 M£ · United Kingdom · Medtech
1nhaler, à Édimbourg, a conçu un inhalateur à dose unique fait surtout de carton, de la taille d'une carte bancaire, qui se déplie au moment de l'usage. Le premier produit l'associe au salbutamol contre l'asthme ; un petit essai doit précéder un dépôt réglementaire visé fin 2027.
Article
Announced on , logged by the watch of 3 November 2026.
- Operation
- Funding round
- Announced amount
- 2,2 M£
- Country
- United Kingdom
- Sector
- Medtech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Archangels , with Scottish Enterprise , BBB Investments
Provenance
Source tech-eu
Logged on 3 November 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.